This company listing is no longer active
1D8 Stock Overview
Singapore O&G Ltd., an investment holding company, provides specialist medical and surgical services for women and children in Singapore.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Singapore O&G Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.28 |
| 52 Week High | S$0.30 |
| 52 Week Low | S$0.24 |
| Beta | 0.88 |
| 1 Month Change | 0% |
| 3 Month Change | -5.09% |
| 1 Year Change | 7.69% |
| 3 Year Change | -25.33% |
| 5 Year Change | -56.92% |
| Change since IPO | -11.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1D8 | SG Healthcare | SG Market | |
|---|---|---|---|
| 7D | 0% | 1.7% | -0.6% |
| 1Y | 7.7% | -20.4% | -3.6% |
Return vs Industry: 1D8 exceeded the SG Healthcare industry which returned -8.6% over the past year.
Return vs Market: 1D8 exceeded the SG Market which returned -3% over the past year.
Price Volatility
| 1D8 volatility | |
|---|---|
| 1D8 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in SG Market | 14.9% |
| 10% least volatile stocks in SG Market | 2.2% |
Stable Share Price: 1D8 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 1D8's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 83 | Eric Choo | www.sog.com.sg |
Singapore O&G Ltd., an investment holding company, provides specialist medical and surgical services for women and children in Singapore. The company operates through four segments: Obstetrics and Gynaecology, Cancer-Related, Dermatology, and Paediatrics. It offers general obstetrics, labor, and delivery; medical problems in pregnancy; and obstetrical complications and its management.
Singapore O&G Ltd. Fundamentals Summary
| 1D8 fundamental statistics | |
|---|---|
| Market cap | S$133.66m |
| Earnings (TTM) | S$8.36m |
| Revenue (TTM) | S$42.66m |
16.0x
P/E Ratio3.1x
P/S RatioIs 1D8 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1D8 income statement (TTM) | |
|---|---|
| Revenue | S$42.66m |
| Cost of Revenue | S$28.36m |
| Gross Profit | S$14.30m |
| Other Expenses | S$5.93m |
| Earnings | S$8.36m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
Aug 11, 2022
| Earnings per share (EPS) | 0.018 |
| Gross Margin | 33.51% |
| Net Profit Margin | 19.60% |
| Debt/Equity Ratio | 0% |
How did 1D8 perform over the long term?
See historical performance and comparison